Effects of Terlipressin and Somatostatin on Portal Pressure in Patients Undergoing Living Donor Liver Transplantation

NCT07304466 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Liver Transplantation
Portal Hypertension

Interventions

DRUG: Somatostatin
DRUG: Terlipressin

Sponsor

Istanbul Medipol University Hospital